Oral Cancer Prevention International and CDx Laboratories have combined forces as CDx Diagnostics. The two companies are focused on developing diagnostic systems designed to help

A new study at McGill University will test the ability of a personal lubricant with a special form of carrageenan gel to prevent the transmission

Reolysin, a drug developed by Oncolytics Biotech to boost the effects of standard chemotherapy drugs, has shown initial positive results in a clinical study of

New findings regarding the genetic mutations that cause head and neck cancer may lead to new therapies, according to collaborative research presented in November at

LED Medical Diagnostics, parent company of LED Dental, has raised $1.2 million for product development, inventory, and working capital through another private placement of company

The Oral Cancer Foundation (OCF) has been honored as the 2012 top-rated nonprofit organization by GreatNonprofits. The award was based on the large number of

Hans Zoellner, BDS, PhD, an associate professor and head of oral pathology at the University of Sydney, has been awarded the 2012 Australian Dental Industry

A recent study from the American Cancer Society that associates heavy coffee drinking with a reduced risk of death from oral cancer is being questioned

Sales of smokeless tobacco products have risen dramatically in California over the last decade, according to a report released December 13 by the California Department

Patients with head and neck cancer (HNC) receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a

The results of a new survey have suggested that Brits are poorly educated when it comes to sexually transmitted diseases such as human papillomavirus (HPV)

A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality (American Journal of Epidemiology, December 9,